Could music be prescribed for conditions such as generalized anxiety disorder? Researchers, musicians and at least one local ...

Catalyst Pharmaceuticals' Firdapse delivers strong growth with a 37% CAGR. Click here to find out why CPRX stock is a Hold.

AppLovin's stock surged 400% in 2024 but dropped 25% amid short-seller attacks. Learn why APP stock appears undervalued with ...

CRDO stock plunges 45% amid growth fears and high valuation. Learn why the recent selloff could be a buying opportunity for ...

I believe we have the opportunity to make multiples of our money as Delivery Hero grows and if multiples expand. Click here ...

The Magnificent 7 underperform amid market rotation. Learn why timing is crucial, with active trading and diversifying into ...

Nvidia Corporation's AI dominance expands as sovereign AI, automation, and efficiency trends emerge. Check out my NVDA stock ...

Target's strengths include a multicategory retail model, strong in-house brands, and a growing digital presence. See why I ...

Class A shares of the Alger Spectra Fund outperformed the Russell 3000 Growth Index during the fourth quarter of 2024. Read ...

Sitio finished 2024 relatively strongly with approximately 40,900 BOEPD (47% oil) in Q4 2024 production. This was a record ...

AppLovin (APP) stock selloff contrasts the company's meteoric rise in 2024 when insider selling of its shares also picked up.